← Snapshot 21

Orange Book snapshot 21: Products

Products page 310 of 799 · 39,901 matching rows.

Source row, Application type, Application number table
Source rowApplication typeApplication numberProduct numberIngredient rawDosage form / route rawDosage formRouteTrade nameApplicantStrength rawTE rawTE JSONApproval dateApproval date rawApproved before 1982RLDRSProduct typeApplicant full nameRaw row SHA-256
15452A211794001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRCIPLA5%AB["AB"]2019-01-18Jan 18, 2019NoNoNoRXCIPLA LTD2c3585443e680e2a704687b45e7f43fcde2d90700665083de5e1af5d27ac7491
15453A205591001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRCOSETTE5%AB["AB"]2017-11-13Nov 13, 2017NoNoNoRXCOSETTE PHARMACEUTICALS INC08614b82979ea6f52e67263e57e0f7c14f72afe503d26f88817f5b5937a66b38
15454A206633001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRFOUGERA PHARMS INC5%AB["AB"]2016-05-11May 11, 2016NoNoNoRXFOUGERA PHARMACEUTICALS INC5a385b54c9c4fdfbf9d181dc698ab7e3741a92c8709e09d663a923ea1a7b796d
15455A205510001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRGLENMARK PHARMS SA5%AB["AB"]2017-07-31Jul 31, 2017NoNoNoRXGLENMARK PHARMACEUTICALS SA SWITZERLAND47830881f38114722feeddd9200005e41895a7950f89e3c734d3b118142c8398
15456A202459001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRMYLAN PHARMS INC5%AB["AB"]2013-04-03Apr 3, 2013NoNoNoRXMYLAN PHARMACEUTICALS INCc2da3950ed17c0e0f46161a87041ee25c2e7400ef6b917bbea66eb47bcdf4c14
15457A205659001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRPERRIGO UK FINCO5%[]2019-02-20Feb 20, 2019NoNoNoDISCNPERRIGO UK FINCO LTD PARTNERSHIPba53bbae30be34b2145ecfe7f92630bb4687916cb3b50a2e5bbc68a5e0cb9cdb
15458A212495001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRSOLARIS PHARMA CORP5%AB["AB"]2020-04-07Apr 7, 2020NoNoNoRXSOLARIS PHARMA CORP4e34fcfc83fb205c82f7124d2dd32c4dc6699d2d50dc35cf7beea2c0af7ab4df
15459A205469001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRTARO5%AB["AB"]2016-12-21Dec 21, 2016NoNoNoRXTARO PHARMACEUTICALS USA INC1106b918e4f0d6f9d127b86a3ea99ae7e5b9cb743c71bd6ba1baf2e31a311241
15460A209971001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRTORRENT5%AB["AB"]2019-01-11Jan 11, 2019NoNoNoRXTORRENT PHARMACEUTICALS LTD5331f2907b0445f8487c1be09462eb7db7c47741a967c2247eb3c4661d740ad2
15461A201501001ACYCLOVIROINTMENT;TOPICALOINTMENTTOPICALACYCLOVIRXIROMED5%AB["AB"]2020-01-29Jan 29, 2020NoNoNoRXXIROMED PHARMA ESPANA SL3f53ca82fd89aa6b078357658535d22bd73e244bd1cfa6030e7697c4d551fb06
15462N050584001ERYTHROMYCINOINTMENT;TOPICALOINTMENTTOPICALAKNE-MYCINBAUSCH2%[]1985-01-10Jan 10, 1985NoYesNoDISCNBAUSCH HEALTH AMERICAS INCb5c5ec2a303a54ca810cdc379e6638f2be496eae2d630f1a1fc8fee52cb52d04
15463A076884001ALCLOMETASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALALCLOMETASONE DIPROPIONATEFOUGERA PHARMS0.05%AB["AB"]2005-07-18Jul 18, 2005NoNoYesRXFOUGERA PHARMACEUTICALS INC810466e8bfb9163fa39d5bacb25433a22ff5ff1469022911a590f3f862444b96
15464A079227001ALCLOMETASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALALCLOMETASONE DIPROPIONATEGLENMARK GENERICS0.05%AB["AB"]2009-07-30Jul 30, 2009NoNoNoRXGLENMARK GENERICS LTDb62199fe029efcd666670692e671aa666f9ba431be2831f262f713db1cc8be15
15465A076730001ALCLOMETASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALALCLOMETASONE DIPROPIONATETARO0.05%AB["AB"]2004-07-29Jul 29, 2004NoNoNoRXTARO PHARMACEUTICALS USA INC97fc025550e90332754cd668ac2303eaa7a55676c26a16c894595928d99ccba2
15466A084944001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALALPHACAINECARLISLE5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNCARLISLE LABORATORIES INC7c7ebb7b52ca708fc15e46732c1b728301066f316ce845ceee366c2655935a01
15467A084946001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALALPHACAINECARLISLE5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNCARLISLE LABORATORIES INC5135f0b13fa6ff62dc116901a940f8633dec14c8c881493d5d8c796249161e43
15468A084947001LIDOCAINEOINTMENT;TOPICALOINTMENTTOPICALALPHACAINECARLISLE5%[]Approved Prior to Jan 1, 1982YesNoNoDISCNCARLISLE LABORATORIES INC54b148044a1a535e19f90b0dd33ac92f1bbe17ce68e6e3ff041469b5e2b2d384
15469N019143001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALALPHATREXSAVAGE LABSEQ 0.05% BASE[]1984-09-04Sep 4, 1984NoNoNoDISCNSAVAGE LABORATORIES INC DIV ALTANA INCba4903b5a27c9b1fef760b01e402d4a16eb976b09f35567fbc9b75a484778a77
15470N022055001RETAPAMULINOINTMENT;TOPICALOINTMENTTOPICALALTABAXALMIRALL1%[]2007-04-12Apr 12, 2007NoYesYesRXALMIRALL LLC047f5e0079d33e7228aa6a02b7621cf64410ffe71fdca776f6cd97cdb86e75e6
15471A076096001AMCINONIDEOINTMENT;TOPICALOINTMENTTOPICALAMCINONIDEFOUGERA PHARMS0.1%AB["AB"]2002-11-19Nov 19, 2002NoNoYesRXFOUGERA PHARMACEUTICALS INC687915b26bf907196d95a0ffccdbe5d2f2f6a9c11dc92a0004dc3462e210fdd1
15472A076367001AMCINONIDEOINTMENT;TOPICALOINTMENTTOPICALAMCINONIDETARO PHARM INDS0.1%AB["AB"]2003-03-19Mar 19, 2003NoNoNoRXTARO PHARMACEUTICAL INDUSTRIES LTD7a67a6929d4b5aff4474ee3f72e43ef3859b3d5458fb2df440bb8b463b987798
15473A080750004TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORTASTELLAS0.1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTELLAS PHARMA US INC5cab95b24b6f2696312f5a59a0142f01305ccc55786aa892542054c14ece8491
15474A080745002TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORTASTELLAS0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTELLAS PHARMA US INC751c3037a667ff1f30804a802d8543391685a922a0efb770be24bc0cc81ac07e
15475A080750003TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORT AASTELLAS0.1%[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTELLAS PHARMA US INC7772737cd56bf855139a580b7e19a5a7f9d85ccf921df8c4001383ff34058fb5
15476A088780001TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORT AASTELLAS0.1%[]1984-10-01Oct 1, 1984NoNoNoDISCNASTELLAS PHARMA US INC7229ca9a24e28ddde48156713f0e606c66c82016b1d10f8df28da1d5e9a40a44
15477A080745003TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORT AASTELLAS0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]Approved Prior to Jan 1, 1982YesNoNoDISCNASTELLAS PHARMA US INCd0ea08509d41272208df19e103ed1278541dac58e966f499a1c3e5236a8c5fe2
15478A088781001TRIAMCINOLONE ACETONIDEOINTMENT;TOPICALOINTMENTTOPICALARISTOCORT AASTELLAS0.5%[]1984-10-05Oct 5, 1984NoNoNoDISCNASTELLAS PHARMA US INC0787db80817138ea172b4daab7520c541eb6bd219e7aa8066f1c5c372cf247e4
15479A062799001BACITRACINOINTMENT;TOPICALOINTMENTTOPICALBACITRACINCOMBE500 UNITS/GM[]1987-05-14May 14, 1987NoNoNoDISCNCOMBE INC2962303efb837ef5d18ffe5e14fb23b74496c36bd82dd1932d99b5b411cc93cd
15480A062857001BACITRACINOINTMENT;TOPICALOINTMENTTOPICALBACITRACINNASKA500 UNITS/GM[]1987-11-13Nov 13, 1987NoNoNoDISCNNASKA PHARMACAL CO INC DIV RUGBY DARBY GROUP COSMETICS6f9a1b044c3f93db97abe648ebe27525f2484a7bb8bd227e39fcbb0e66ac900b
15481A062833001BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEOINTMENT;TOPICALOINTMENTTOPICALBACITRACIN ZINC-NEOMYCIN SULFATE-POLYMYXIN B SULFATENASKA400 UNITS/GM;EQ 3.5MG BASE/GM;5,000 UNITS/GM[]1987-11-09Nov 9, 1987NoNoNoDISCNNASKA PHARMACAL CO INC DIV RUGBY DARBY GROUP COSMETICS1fe71494d9cde51d953337fd33124dc3a6f2ff90e7dcc6abceaef21639caab4f
15482A062849001BACITRACIN ZINC; POLYMYXIN B SULFATEOINTMENT;TOPICALOINTMENTTOPICALBACITRACIN ZINC-POLYMYXIN B SULFATENASKA500 UNITS/GM;10,000 UNITS/GM[]1987-11-13Nov 13, 1987NoNoNoDISCNNASKA PHARMACAL CO INC DIV RUGBY DARBY GROUP COSMETICS58539e05ff3d5f3ab4a609bb5da37539dd84c50808f161546174634cadbcf16b
15483N050591001MUPIROCINOINTMENT;TOPICALOINTMENTTOPICALBACTROBANGLAXOSMITHKLINE2% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**[]1987-12-31Dec 31, 1987NoYesNoDISCNGLAXOSMITHKLINEb0387cf923c225e733669bfce814bd709ccee6094d6d81a769a12aadc3374483
15484A070069001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETA-VALCOSETTEEQ 0.1% BASEAB["AB"]1985-12-19Dec 19, 1985NoNoNoRXCOSETTE PHARMACEUTICALS INC9b252e28cd9b260a6e657b3fdbfd991bdacbd8dd480627c7678eeb1c1c9fa8a0
15485A071012001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATEACTAVIS MID ATLANTICEQ 0.05% BASEAB["AB"]1987-02-03Feb 3, 1987NoNoNoRXACTAVIS MID ATLANTIC LLC4fcf655f4d64ae55f21c95f790dc5592e61322887954e62e5ab58589d24abaa5
15486A214048001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATECADILAEQ 0.05% BASEAB["AB"]2020-07-14Jul 14, 2020NoNoNoRXCADILA HEALTHCARE LTD4bbc2b3c570519982e28707734f2d8ddd97d032f6745717f0697bbb00c8bf819
15487N019141001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATEFOUGERA PHARMS INCEQ 0.05% BASEAB["AB"]1984-09-04Sep 4, 1984NoYesYesRXFOUGERA PHARMACEUTICALS INC3283735288aa43a3024352678fd68c38b2f26fc628a840892a0d8ae6ea8a0456
15488A072526001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATEPERRIGO NEW YORKEQ 0.05% BASE[]1990-01-31Jan 31, 1990NoNoNoDISCNPERRIGO NEW YORK INC6e541ff533716882ec9e044b60658cf8c06467b5d7f5b5d94f247add75239f7a
15489N019140001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATEPHARMADERMEQ 0.05% BASE[]1984-09-04Sep 4, 1984NoNoNoDISCNPHARMADERM DIV ALTANA INC1190f20116bfb251d23314c218800059fa37c8b237bbc25fdc8151638df03a89
15490A074271001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATETAROEQ 0.05% BASEAB["AB"]1994-09-15Sep 15, 1994NoNoNoRXTARO PHARMACEUTICALS USA INCf2e6068d6b0c41b25d7b2bd34972bc71ea1a31667eb75f12d94111ab940e0c62
15491A071477001BETAMETHASONE DIPROPIONATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE DIPROPIONATETEVAEQ 0.05% BASE[]1987-08-10Aug 10, 1987NoNoNoDISCNTEVA PHARMACEUTICALS USA INC5e8a3cb48ffb5ba55b024bed4562565b2af900a01918fb9e554cd4955a9c0d95
15492A070051001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE VALERATEACTAVIS MID ATLANTICEQ 0.1% BASEAB["AB"]1984-10-10Oct 10, 1984NoNoNoRXACTAVIS MID ATLANTIC LLCf368665c0db9f239cbb19a07cd77ea889480ef6afed1ae22a6ff25f53e8b4d92
15493N018865001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE VALERATEFOUGERA PHARMS INCEQ 0.1% BASEAB["AB"]1983-08-31Aug 31, 1983NoYesYesRXFOUGERA PHARMACEUTICALS INCd13e978f4e3c3aac7a1ef66c2c781c8c254122929045425a49bd6bd711650eb3
15494A071478001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE VALERATEPERRIGO NEW YORKEQ 0.1% BASE[]1987-12-23Dec 23, 1987NoNoNoDISCNPERRIGO NEW YORK INC3611c7b45b8d8cf27296bf26a25011860b2755dd6a8531327e7e04189a8a9744
15495N018864001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE VALERATEPHARMADERMEQ 0.1% BASE[]1983-08-31Aug 31, 1983NoNoNoDISCNPHARMADERM DIV ALTANA INCc556660a1c7098641b748f5151b14aa4f333ac1f323ba16cb9a73f5ecc3211be
15496A070486001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETAMETHASONE VALERATEPHARMAFAIREQ 0.1% BASE[]1987-05-29May 29, 1987NoNoNoDISCNPHARMAFAIR INC484b93e861949c559692c35bd7e1c429ad3f9fc1a2c82ddeb1fb33f50c56e2c2
15497N018863001BETAMETHASONE VALERATEOINTMENT;TOPICALOINTMENTTOPICALBETATREXSAVAGE LABSEQ 0.1% BASE[]1983-08-31Aug 31, 1983NoNoNoDISCNSAVAGE LABORATORIES INC DIV ALTANA INC2ad06ad6d6aa44484162b83f462b062c997f6579e36af3d36562eb268056cf15
15498A090633001CALCIPOTRIENEOINTMENT;TOPICALOINTMENTTOPICALCALCIPOTRIENEGLENMARK PHARMS INC0.005%[]2010-03-24Mar 24, 2010NoNoYesRXGLENMARK PHARMACEUTICALS INC USAb795f151ed1450f02c5d88a6936bf265d10752b14b364c646ac77a07e3c6afe0
15499A200174001BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEOINTMENT;TOPICALOINTMENTTOPICALCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEPERRIGO UK FINCO0.064%;0.005%AB["AB"]2014-12-12Dec 12, 2014NoNoNoRXPERRIGO UK FINCO LTD PARTNERSHIP6d3fc7e8f4cce14745f55d0e0cdc1376c5f37e830ef62bfad258ba651f1c5771
15500A201615001BETAMETHASONE DIPROPIONATE; CALCIPOTRIENEOINTMENT;TOPICALOINTMENTTOPICALCALCIPOTRIENE AND BETAMETHASONE DIPROPIONATETOLMAR0.064%;0.005%AB["AB"]2013-01-14Jan 14, 2013NoNoNoRXTOLMAR INC955b452c69ff905f75adc9bc3de3bf874ff459b3266dc9773207120c83ff1518
15501N050788001MUPIROCINOINTMENT;TOPICALOINTMENTTOPICALCENTANYPERRIGO NEW YORK2%BX["BX"]2002-12-04Dec 4, 2002NoNoNoRXPERRIGO NEW YORK INC62cd9ac993858cdccb1c9744e351755745db23395243e6d9a189486fe4f2aaf5